Middle East And Africa Acute Coronary Syndrome Market Analysis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 SERVICES LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTERS FIVE FORCES

5 MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET: REGULATORY SCENARIO

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES, SUCH AS CORONARY ARTERY DISEASE, ISCHEMIC HEART DISEASE, AND VASCULAR DISEASES

6.1.2 GROWING GERIATRIC POPULATION

6.1.3 WIDE RANGE OF PRODUCTS OFFERED BY MARKET PLAYERS

6.1.4 IMPROVING HEALTHCARE INFRASTRUCTURE AND REIMBURSEMENT POLICIES

6.2 RESTRAINTS

6.2.1 RISE IN COST OF THERAPEUTIC SURGERY

6.2.2 STRINGENT RULES & REGULATIONS

6.3 OPPORTUNITIES

6.3.1 SURGE IN TECHNOLOGICAL ADVANCEMENTS FOR CARDIOVASCULAR DISEASE

6.3.2 RISING HEALTHCARE EXPENDITURE

6.3.3 INCREASED REIMBURSEMENT POLICIES

6.3.4 RISING DISEASE MANAGEMENT PROGRAMS

6.4 CHALLENGES

6.4.1 LACK OF ACCESSIBILITY OF SERVICES

6.4.2 LONG PROCESS OF APPROVAL BY REGULATORY BODIES

7 MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET, BY TYPE

7.1 OVERVIEW

7.2 NON-ST- ELEVATION MYOCARDIAL INFARCTION

7.3 ST-ELEVATION MYOCARDIAL INFARCTION

7.4 UNSTABLE ANGINA

8 MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS

8.1 OVERVIEW

8.2 STRESS TEST

8.3 BLOOD TEST

8.4 IMAGING

8.5 OTHERS

9 MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET, BY TREATMENT

9.1 OVERVIEW

9.2 MEDICATION

9.3 SURGERY

10 MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS AND CLINICS

10.3 DIAGNOSTIC CENTERS

10.4 ACADEMIC INSTITUTES

10.5 OTHERS

11 MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET, BY REGION

11.1 MIDDLE EAST & AFRICA

11.1.1 SOUTH AFRICA

11.1.2 SAUDI ARABIA

11.1.3 UAE

11.1.4 EGYPT

11.1.5 ISRAEL

11.1.6 REST OF MIDDLE EAST & AFRICA

12 MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 NOVARTIS AG

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.1.5.1 PRODUCT EXPANSION

14.1.5.2 COLLABRATION

14.2 ASTRA ZENECA

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.2.5.1 ACQUISITION

14.3 AMGEN INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 SANOFI

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.4.5.1 ACQUISITION

14.5 BAXTER

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENTS

14.6 DR. REDDY’S LABORATORIES LTD.

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENTS

14.6.4.1 ACQUISTION

14.7 PFIZER INC.

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 MERCK & CO., INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENTS

14.8.4.1 EVENT

14.8.4.2 ACQUISTION

14.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.9.3.1 PRODUCT APPROVAL

14.1 CSL

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENT

14.10.4.1 ACQUISITION

14.11 DAIICHI SANKYO COMPANY,LIMITED

14.11.1 COMPANY SNAPSHOT

14.11.2 REVENUE ANALYSIS

14.11.3 PRODUCT PORTFOLIO

14.11.4 RECENT DEVELOPMENT

14.11.4.1 PARTNERSHIP

14.12 JOHNSON & JOHNSON SERVICES, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 REVENUE ANALYSIS

14.12.3 PRODUCT PORTFOLIO

14.12.4 RECENT DEVELOPMENT

14.12.4.1 ACQUISITION

14.13 TEVA PHARMACEUTICAL INDUSTRIES LTD.

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENT

14.13.4.1 ACQUISITION

14.14 REGENERON PHARMACEUTICALS INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS